Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs THC✓SelectedUSD · THCMRNA vs THC performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs THC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-25.4%
THC return
+247.4%
Excess return
-272.8%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioTHCExcessAlpha
1D-4.8%-3.8%-1.0%-4.1%
7D-20.9%-7.4%-13.5%-19.6%
30D-13.3%+1.9%-15.1%-13.4%
3M+212.6%+0.4%+212.1%+212.2%
6M+309.0%+41.0%+268.0%+278.4%
YTD+567.3%+36.5%+530.8%+516.1%
1Y+689.7%+40.6%+649.1%+623.1%
3Y+157.4%+325.7%-168.3%+75.9%
All-25.4%+247.4%-272.8%-46.2%

Cumulative growth

Daily Returns

Daily percentage return beside THC.

Daily Out/Under-Performance

Portfolio return minus THC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling